6634 ªYÄ£
ªÑ¥»: 3.832»õ
¥Dn·~°È:
¨xŦ¯e¯fªvÀø¤Î¯kµhªvÀø¬ÛÃöÃĪ«¬ã¨s¤Î¶}µo
¸³ºÊ«ùªÑ¤ñ¨Ò: 21.7%(¼W¥[¤¤)
¥~¸ê«ùªÑ¤ñ¨Ò: 0.22%(¼W¥[¤¤)
Ä~Äò©¹¤U¬Ý...!
=============================================================================
²£«~01¡GSNP-610 (ªvÀø¯×ªÕ¨x¯e¯f·sÃÄ)
¾AÀ³¯g: «D°sºë©Ê¯×ªÕ¨xª¢
²£«~Àu¶Õ:
1.¥Ø«e©|µL¼Ð·ÇªvÀøÃĪ«
2.¥«³õº¨£·sÃÄ(First-in-class)
3.¦P®É¥i¥Î©ó°sºë©Ê©M«D°sºë©Ê¯×ªÕ¨x
4.µL¦w¥þ©Ê°ÝÃD
¥«³õ: «D°sºë©Ê¯×ªÕ¨xª¢¥þ²y¥«³õ¨C¦~¬ù350-400»õ¬ü¤¸¡C
Ävª§¤O:
1.¦h«§@¥Î¾÷Âà:ªvÀø¤Î¹w¨¾¯×ªÕ¨xª¢
2.ª½±µ§@¥Î©ó¨xŦ¡AªvÀø¯×ªÕ¨xª¢¡A°§C¨x¯×
3.¥i´£¥X¨uÃĥӽСAÀ³¥Î©óªvÀø§³®W«æ©Ê¯×ªÕ¨x
¬ãµo¶¥¬q:
1.¤w³q¹LUSFDA¤ÎTFDA¼f¬d¶i¤JÁ{§É¤G´Á
2.Á{§ÉÀø®Ä¤Î·sªvÀø¾÷ÂàÅçÃÒ
Àø®Ä¤ÀªR¡G
1.²Ä¤@´ÁÁ{§É¸ÕÅç¡Gµ²ªGÅã¥Ü¤HÅé¨Ï¥Î¦w¥þ¡A©Ê½è¨}¦n
2.²Ä¤G´ÁÁ{§É¸ÕÅç¨ä¤¤¤ÀªR¡G17¦ìNASH ¯f¤H (p=0.009)
=============================================================================
²£«~02¡GSNP-630
¾AÀ³¯g:«D°sºë©Ê¯×ªÕ¨xª¢
²£«~Àu¶Õ:
1.¬°Àu¤Æ(Optimized)¤§·s¤Æ¾Ç¹êÅé(NCE)
2.¥«³õº¨£·sÃÄ(First-in-class)
3.¦P®É¥i¥Î©ó°sºë©Ê©M«D°sºë©Ê¯×ªÕ¨x
4.§@¬°²Ä¤@¥N²£«~¤W¥««áªº±µÄò¦û¦³¥«³õ¤§²£«~
¥«³õ: «D°sºë©Ê¯×ªÕ¨xª¢¥þ²y¥«³õ¨C¦~¬ù350-400»õ¬ü¤¸¡C
Ävª§¤O:
1.¦h«§@¥Î¾÷Âà:ªvÀø¤Î¹w¨¾¯×ªÕ¨xª¢
2.ª½±µ§@¥Î©ó¨xŦ¡AªvÀø¯×ªÕ¨xª¢¡A°§C¨x¯×
3.Àu¤ÆªºÀø®Ä±j«×¡B§@¥Î®É¶¡
4.µL¦w¥þ©Ê°ÝÃD
¬ãµo¶¥¬q:
1.Á{§É«e
2.¹w©w¥Ó½Ð¬ü°êFDAIND¡B§Ö³t³q¹D(fasttrack)¡C
3.¥Ó½Ð¬ü°ê¬ð¯}©ÊªvÀø(breakthrough therapy)ªº»{©w¡C
Àø®Ä¤ÀªR¡G
1. ¥Ø«e¦b°Êª«¤W¥H¤£¦P¾¯¶q¶i¦æ¸ÕÅç¡Aµ²ªGÅã¥Ü p<0.05
=============================================================================
²£«~03¡GSNP-810 (µL¨x¬r©Ê¤îµh·sÃÄ¡B¸Ñ¬r¾¯)
¾AÀ³¯g: µL¨x¬r©Ê¤AñQÓi×ô¤îµhÃÄ (¸Ñ¼öÂíµh¾¯)
²£«~Àu¶Õ:
1.¦w¥þ¤Æ¦Xª«·s²Õ¦X¡BµL¨x¬r©Ê
2.¸Ñ¨M¢¤ÁÂåÀø»Ý¨D (Important urgent unmet medical needs)
3.¦³¾¯«¬±M§Q¡A¦w¥þ½d³ò¤j¡A¥iקï©Î§R°£FDA¨x¬rĵ»y¥i¼W¥[¾¯¶q
¥«³õ: ¤AñQÓi×ô¶È¦b¬ü°ê¤@¦~´N¦³40»õ¬ü¤¸ªº¥«³õ
Ävª§¤O:
1.¥«³õ¤WµLÃþ¦üµL¨x¬r©Ê¤§Ävª§ÃĪ«
2.¥i§ð¦û¼s¤j¥«³õ¡]NSAID, COX-2 §í¨î¾¯¡BOpioidsÃþ¤îµhÃÄ¥«³õ¡^
3.¥i¬Ù°£¶D³^¶O¡B±Ð¨|°V½m¶O
¬ãµo¶¥¬q:
1.¤w§¹¦¨§C¾¯¶q¡B°ª¾¯¶qÁ{§É¸ÕÅç
2.¤w¥Ó½ÐUSFDA¼Ï纽Á{§É¸ÕÅç¡B±N¥Ó½Ð¬ð¯}©Ê¼f¬d/§Ö³t³q¹D
3.µL¨x¬r©Ê¤AñQÓi×ô¸Ñ¬r¾¯¦¨¤À¡A¤w¥Ó½Ð¬dÅçµn°O¥Î¤§Á{§É¸ÕÅç
=============================================================================
²£«~04¡GSNP-830/ SNP-840
¾AÀ³¯g: µL¨x¬r©Ê¤AñQÓi×ô¤îµhÃĽƤè(ªvÀø¤¤¡B««×¯kµh)
²£«~Àu¶Õ:
1.µL¨x¬r©Ê¤AñQÓi×ôªº½Æ¤è
2.¦³¾¯«¬±M§Q¡A¦w¥þ½d³ò¤j¡A¥iקï©Î§R°£FDA¨x¬rĵ»y¡A¥i¼W¥[¾¯¶q
¥«³õ: ¤AñQÓi×ô³B¤èÃĦb¬ü°ê¤@¦~´N¦³27»õ¬ü¤¸ªº¥«³õ
Ävª§¤O:
1.¥«³õ¤WµLÃþ¦üµL¨x¬r©Ê¤§Ävª§ÃĪ«½Æ¤è
2.½Æ¤è¤w¥Ñ¬ü°êFDAn¨D°¾¯¶q§C©ó325²@§J¡A±N¼vÅTÀø®Ä
3.¦³¨Ï¥Î±M§Q¡A¥iקï©Î§R°£FDA¨x¬rĵ»y
4.¥i¼W¥[¤AñQÓi×ô¾¯¶q
¡]¥Ñ325mg ¦^´_¦Ü500 mg¬Æ¦Ü§ó°ª¡A·|¸û¦³®Ä¡^¥H¼W¥[Àø®Ä¡A©Î´î¤ÖOpioids¾¯¶q¡A°§C¦¨Å}°Æ§@¥Î
5.¤GªÌ¾Ü¤@±ÂÅv
6.¥i¼W¥[¥«¦û²v
¬ãµo¶¥¬q:
1.SNP-810¨ú±oÃÄÃÒ«á¡A¶i¦æÁ{§É¸ÕÅç§t¬Ûµ¥©Ê¸ÕÅç
SNP-830 ¤£¬O ·s¦¨¤À ªº·sÃÄ¡A©Ò¥H¤£»Ýn¶i¦æ²Ä¤@¡A¤G¤Î¤T´ÁÁ{§É´úÅç
µ¥ SNP-810 ®³¨ìÃÄÃÒ«á¡A¥H ·sÀø®Ä½Æ¤è¶i¦æÁ{§É¸ÕÅç§t¬Ûµ¥©Ê´úÅç ´N¥i¥HÀò±oÃÄÃÒ
=============================================================================
*****************************************************************************
SNP-8 ¨t¦C Àø®Ä¤ÀªR¡G
1. ¦b°Êª«¤W¥H¤£¦P¾¯¶q¶i¦æ¸ÕÅç¡Aµ²ªGÅã¥Ü p<0.005
1. ¤w¸g§¹¦¨¤§¤HÅé¸ÕÅç¡Aµ²ªGÅã¥Ü p<0.005
=============================================================================
*****************************************************************************
¥¼¨Ó¥Ø¼Ð±ÂÅv¥D¤O²£«~¡G
1. ¯×ªÕ¨xÃÄ¡GSNP-610 ©M SNP-630 ¦U¦³ÀuÂI¡A¥Ø¼Ð¬°¥þ²y±ÂÅv
2. ¤îµhÃÄ(OTC): SNP-810, ¥Ø¼Ð¬°¬ü°ê¤Î¥þ²y±ÂÅv
3. ¤îµhÃÄ(³B¤èÃÄ): SNP-830 ¤Î SNP-840, ¦b°Êª«¤W¬Ò¦³¥¿±ªºµ²ªG¡A¥Ø¼Ð¬°¥þ²y±ÂÅv
=============================================================================
*****************************************************************************
¥Ø«e¤½¥q»P°ê»Ú¤j«¬Ãļt¥¿¦b½Í§Þ³N±ÂÅv©M¦X§@p¹º
§Ú¬Ý¹L¤½¥q©xºô©M©Ò´£¨Ñªº¸ê®Æ¡Aı±o¤½¥q«Ü¥Î¤ß¦b¸gÀç¡A¦Ó¥B¸ê®Æ¤]«Ü¸Ô²Ó
¹ï¤½¥qµo®i«Ü¦³¦Û«H¡A¥¼¨ÓªÑ»ùȱo´Á«Ý¡A¦³¾÷·|¬O ¤U¤@Ó ¦X¤@ ÄƪÑ
-----------------------------------------------------------------------------
¥H¤W¸ê®Æ ³£°Ñ¦Ò ªÑªF·|ij¨Æ¿ý.pdf ©M ¤½¥q©xºô (¦³¿³½ìµÛÅwªï¦A²`¤J¬ã¨s»P°Q½×)
ªYÄ£:¸ÑÂê40¦~¨x¬r©Ê°ÝÃD(¯àªA¥Î§ó°ªªº¾¯¶q»Pªø®É¶¡ªA¥Î)
±ÂÅv¾÷²v?
------------------------------------------------------------------------------------------------
·|û¡GROGER588910148151 µoªí®É¶¡:2022/11/27 ¤W¤È 11:12:21²Ä 2686 ½g¦^À³
2022.8¤ë-J&J¶}µoªºµL¨x¬rTylenol(JNJ-10450232)¬ã¨s³ø§i
www.sciencedirect.com/science/article/abs/pii/S0273230022001234
...¦pªG«ö·Ó²£«~¼ÐÅÒªº«ü¥Ü¨Ï¥Î¹ï¤A酰®ò°ò×ô¡]¼³¼ö®§µh¡^¡B¥¬¬¥ªâ¡B萘´¶¥Í¡BÂù´âªâ»Ä©Mªü¥q¤ÇªL¬O¦³®Ä¥B¦w¥þªº¡A¦ý¦pªG¥H°ª©ó±ÀÂ˪º¾¯¶q©M/©Î§óªøªº«ùÄò®É¶¡ÀݥΥ¦Ì¡A«h¤£¨}¤ÏÀ³ªº·ÀI·|¼W¥[¡C¦]¦¹¡A[´À¥NÂíµhÃĪº¶}µoºc¦¨¤F¤@Óªø´Á¥¼º¡¨¬ªº»Ý¨D¡C]
³Ì¦nªº¼@¥»¬O¦b¦~©³¦X§@±ÂÅv¦¨¥\¡A©ú¦~3¤ë«e¤W¤£¤W´N¤£«n¤F¡C
¾Ç¤@¤U±Ó¦¨ötÓ70%
¨ú±o²Ä¤T¤èÅçÃÒ³æ¦ì¥¿¦¡¸ÕÅç³ø§i¡AÃÒ¹êSNP-810µL¨x¬r©Ê¡C
ªYÄ£¨S¸Ô»¡¡A¤]¨S¤H¸ß°Ý¤½¥q?¶K½g¬ü°ê¦P¦æµoªí¬ã¨s½×¤å¡A¦³¿³½ìªÌ¦Û¦æ±ÀºV«ä¦Ò¡C
2021.9.30 ¨Ï¥Î¹ï¤A酰®ò°ò×ô¨x¬r©Ê¼Ò«¬¶i¦æ¾÷²z¬ã¨sªº«Øij¥H¤Î¦p¦óÁקK±`¨£ªº³´¨À
www.sciencedirect.com/science/article/pii/S2211383521003828
¨Ï¥Î APAP ¨x¬r©Ê¼Ò«¬®É³Ì±`¥Çªº¿ù»~
abcnews.go.com/Health/wireStory/cvs-walgreens-finalize-10b-settlements-opioids-95090148
CVS ©M Walgreens ¤w¦P·N¦V¦{©M¦a¤è¬F©²¤ä¥IÁ`p¶W¹L 100 »õ¬ü¤¸ªº¶O¥Î¡A¥H¤Fµ²¦³Ãöªü¤ùÃþÃĪ«¦¬¶Oªº¶D³^¡A²{¦b·Qª¾¹D¦U¦{¬O§_·|¦b 12 ¤ë 31 ¤é¤§«e±µ¨ü³o¨Ç¥æ©ö¡C
³o¨Ç¥æ©ö¬Oªñ¦~¨ÓÀÀij©M³Ì²×¹F¦¨ªºªü¤ùÃþÃĪ«©M¸Ñ®ö¼é¤¤³W¼Ò³Ì¤jªº¤@µ§¡AÁ`ÃB¶W¹L 500 »õ¬ü¤¸¡C¥t¤@®a¤j«¬ÃĩйBÀç°Ó¨Uº¸º¿¤WÓ¤ë¤]¦P·N¥H 31 »õ¬ü¤¸¹F¦¨©M¸Ñ
Ãö©ó±ÂÅv¦X¬ù¤º®e¬O¦r¦rp¸û¨ì»P·|¤Hû³£nñ¦b¦X¬ù¸Ì
ÁקK¥¼¨Ó³Q¥t¥~¶}µo¡A¨ì®É¯uªº·|±ýúµL²\
IPO©µ´Á´N©µ´Á§a¡I¦X¬ù½Í¦n¤ñ¸û«n¡C
================================
¦P·N¡A¦³¹w·PÁÙ¯uªº·|©µ´Á
=================================================
«D±`¦P·N¡A¦ý¸U¤@©µ´Á®ø®§¤@¥X¨Ó¡A¿³¶Q¤j«ã¯«´N¦nª±¤F!!µ¹¥D¤O¤W¨® ¤W¤U¨ä¤âªº¾÷·|
¤]µ¹¤pªÑ¥Á¾ß«K©yªº¾÷·|
·~¬ÉªºÁnµ¡A¨S¤J¥DºÞªº¦Õ!
2017.10.16--¥Í§Þ¥H¬ì§Þ¨Æ·~¥Ó½Ð¤WÂd ²£©x¾ÇÆ~©µªø®Öã¨ç®Ä´Á
www.chinatimes.com/newspapers/20171016000145-260210?chdtv
³Í°òÃҨ鸳¨Æªø³\¹D¸q¡G...³\¹D¸q»{¬°©Ó¾P°Ó§@²Ä1¼h§âÃö¡A¨ú±o¥¿ÅÂI¡A¥H¬ì§Þ¨Æ·~¤¤IC¥b¾ÉÅé²£·~®É¶¡¸ûµu¡A¦]¦¹¨ú±o¤u·~§½®Öã¨çªº1¦~´ÁÁÙ¥i¥H¡A¦ý¥Í§Þ·sÃĬãµo¤£¬O1¦~´N¥i¥H¬Ý¥X¦¨ªG¡A®É¶¡¸û¬°º©ªø¡A¥Í§Þ²£·~ªº®É¶¡¥i¥H©µªø¬°1¦~¥b©Î¨â¦~¡F
---------------------------------------------------------------------------------------------------
·|û¡G¶ø¥ì´µ¯S10031727 µoªí®É¶¡:2022/9/13 ¤U¤È 04:01:08²Ä 2454 ½g¦^À³
J SIR »¡¹L¡A±ÂÅv½Í§P¹Lµ{n«ÜÄYÂÔ¥B¯Ó®É¡A¦X¬ù¤å¦r¤Wªº¥[µù»P¨î¥²¶·n¨ì¦ì¡C
Y¤½¥q±ÂÅv¤§«á¤~¨««áÄò IPO ¬yµ{ªº¸Ü¡A§Ú±À´ú¤µ¦~¥i¯à¤£·|¤W¥«¡AIPO ¥u¬O¹Lµ{¡A±ø¥ó½Íªº¦n¤~¬O«ÂI¡A¤£¥²¬°¤F IPO ®Éµ{¥h§´¨ó±ÂÅv±ø¥ó¡A³o¬O¥»¾¥Ë¸m¡C
---------------------------------------------------------------------------------------------------
·|û¡GNtumgk10151447 µoªí®É¶¡:2022/9/14 ¤W¤È 04:26:46²Ä 2461 ½g¦^À³
To ½Ñ¦ì¤j¤j
®Ú¾Ú¤p§Ì©ó«e´XÓ§«ôP¹q¤½¥q¸ß°Ýªºµ²ªG¡A¤WÂd®Éµ{¦w±ÆÀ³¸Ó¬O·|¸¨¦b©ú¦~H1¡C
...¦]¬°¦b¤@¨Ç¬ã¨s¤¤¹v¦V RIPK3 ¤¶¾ÉªºÃa¦º©Êä¤`¥i¦³®Ä¹w¨¾ [APAP]»¤¾Éªº«æ©Ê¨x°IºÜ
------------------------------------------------------------------------------------------------
SNP-810¬°µL¨x¬r©Ê¤îµh¬O¥H»Ã¯À§í¨î¾¯¨Ï[APAP]¬r©Ê¥NÁª«¤£¦A¥Í¦¨!
F4(ÄY«ÅÖºû¤Æ)---¥NÀv©Ê¨xµw¤Æ(SNP-610)»P¥¢¥NÀv©Ê¨xµw¤Æ¡C
------------------------------------------------------------------------------------------------
·|û¡GROGER588910148151 µoªí®É¶¡:2022/12/12 ¤W¤È 10:03:20²Ä 2709 ½g¦^À³
..¨ä¤¤ RIPK3 ´`Àô¤ô¥¤É°ª»P±wªÌ±q AD ¶i®i¬° ACLF¡BACLF ªºÄY«µ{«×©Mµu´Á¦º¤`²v¬ÛÃö¡Cºî¤W©Òz¡A¸Ó¬ã¨sªí©ú¡A´`Àô RIPK3 ¥i¯à§@¬°¤@ºØ¼ç¦bªº¥Íª«¼Ð»xª«¡A¥Î©ó¿ï¾Ü±wªÌ±µ¨ü°w¹ïRIPK1 ¤¶¾Éªº²ÓM¦º¤`ªºÃĪ«ªvÀø¡C
------------------------------------------------------------------------------------------------
·|û¡GROGER588910148151 µoªí®É¶¡:2021/11/26 ¤U¤È 11:16:17²Ä 1488 ½g¦^À³
¡K.SNP-610´Á¤¤¤ÀªR¦³¨xŦÅÖºû±½´y»öFibroscan data¡AF4(ÄY«ÅÖºû¤Æ)ªvÀø«e«á [¦³ÅãµÛ]®t²§¡C
1. 2012.12.14-aasldpubs.onlinelibrary.wiley.com/doi/full/10.1002/hep.26200
¬ã¨sªí©ú¡ACYP2E1 ¹ï RIPK3 ªºªí¹F°µ¥X¤F«¤j°^Äm!
CYP2E1 ªº¯Ê¥¢°fÂà¤F¤A¾J¤¶¾Éªº RIPK3 ªí¹F¡A¦Ó RIPK3 ªº¯ÓºÜ¨Ã¥¼§ïÅܤA¾J³B²z»¤¾Éªº CYP2E1 ªí¹F¤É°ª¡Aªí©ú
CYP2E1 §@¬° RIPK3 ªº¤W´å°^ÄmªÌ¡C
2. 2022.6.23 -www.nature.com/articles/s41419-022-05009-y
¤HÃþ RIPK3 C¸ÁC»Ä¤Æ¹ï©óÃa¦º«H¸¹¶Ç¾É¦ÜÃö«n
3. 2021.12.17 www.nature.com/articles/s41419-021-04442-9
³o¨Ç¼Æ¾Ú[º¦¸ÃÒ©ú]¤F RIPK1 ¤¶¾Éªº²ÓM¦º¤`¦b¤HÃþ©Mø¥¾¦°Êª« ACLF ¤¤ªº«n©Ê¡C
§Ṳ́§«e´¿³ø¾É¹L ACLF ±wªÌµo¥Í«Dä¤`©Ê²ÓM¦º¤`ªº«n©Ê [ 9 ]¡CACLF ±wªÌ RIPK3 ´`Àô¤ô¥ªºÅãµÛ¼W¥[¤ä«ù
RIPK1 ¤¶¾Éªº²ÓM¦º¤`¥i¯à¬O¨ä§@¥Î¾÷¨îªºÆ[ÂI¡CRIPK3 »P RIPK1 ©M pMLKL ¤@°_¬OÃa¦º©Êä¤`³~®|ªºÃöÁä²Õ¦¨³¡¤À¡C
«nªº¬O¡ARIPK3 ¤ô¥»P¥þ¨ª¢¯g¼Ð»xª«±K¤Á¬ÛÃö¡A³o¤w³QÃÒ©ú¬O ACLF µo®iªº®Ö¤ß¾÷¨î
¦]¬°¦b¤@¨Ç¬ã¨s¤¤¹v¦V RIPK3 ¤¶¾ÉªºÃa¦º©Êä¤`¥i¦³®Ä¹w¨¾ APAP »¤¾Éªº«æ©Ê¨x°IºÜ¡A¦ý¦b¨ä¥L¥O¤H¾á¼~ªº¬O¡A¦b¤M¨§
²y³J¥Õ A (ConA) »¤¾Éªº¦Û¨§K¬Ì©Ê¨xª¢¤¤¡ARIPK3 ¯Ê¥¢¨ã¦³«OÅ@§@¥Î¡A¦Ó RIPK1 §í¨î·|¥[¼@¯e¯f¡B¥[³t°Êª«¦º¤`¡A¨Ã
¥B»P¨x²ÓM¦º¤`¼W¥[¦³Ãö¡C
³o¤@Æ[¹îµ²ªG±o¨ì¤F¨âÓ±wªÌ¶¤¦C¼Æ¾Úªº¤ä«ù¡A¨ä¤¤ RIPK3 ´`Àô¤ô¥¤É°ª»P±wªÌ±q AD ¶i®i¬° ACLF¡BACLF ªºÄY«µ{«×
©Mµu´Á¦º¤`²v¬ÛÃö¡Cºî¤W©Òz¡A¸Ó¬ã¨sªí©ú¡A´`Àô RIPK3 ¥i¯à§@¬°¤@ºØ¼ç¦bªº¥Íª«¼Ð»xª«¡A¥Î©ó¿ï¾Ü±wªÌ±µ¨ü°w¹ï
RIPK1 ¤¶¾Éªº²ÓM¦º¤`ªºÃĪ«ªvÀø¡C
1.2022.9.22-ªYÄ£¤îµhÃÄÅçÃÒ µL¨x¬r©Ê(±Nµ²ªG´£¨Ñµ¹¦³»P¤½¥qñq¦³Àv¦X¬ù¤§°ê»Ú¤îµhÃļt°Ó)
2.2022.10.17JP¦b¬ü°êÃľǮa¦~·|µoªí-«D°sºë©Ê¯×ªÕ¨x©w¶q¨x¥\¯àÀË´ú
eventscribe.net/2022/PharmSci360/fsPopup.asp?Mode=posterinfo&PosterID=528564
3.2022.10.19-ªYÄ£¯×ªÕ¨xª¢·sÃĤG´ÁÁ{§Éµ²ªG ¦b¬ü°êÃľǮa¦~·|µoªí
4.2022.10.30-ªYÄ£¤îµh·sÃĸÑÂê40¦~¨x¬r©Ê°ÝÃD °ê»Ú¤j¼t±ÂÅv¦b±æ(¦¶¸³±µ¨ü¤¤¥¡ªÀ±M³X)¡u¿ïÃD¡B¤H¤~¡B´¼¼z°]²£«OÅ@¦n¤£¦n¡B°]°È±Ã©w«×¡A³£¬O·sÃĤ½¥q¦¨¥\ªº¥ý¨M±ø¥ó¡v
·sÃĶ}µo_¿ïÃD
www.facebook.com/100064104724409/videos/1202540343488971/?__so__=watchlist&__rv__=video_home_www_playlist_video_list
--------------------------------------------------------------------------------------------------
·|û¡GROGER588910148151 µoªí®É¶¡:2022/5/9 ¤U¤È 08:52:57²Ä 1956 ½g¦^À³
05_·sÃĶ}µo_¿ïÃD
J¤j¯«¦b14:15¬í°_:...½Í¨ì³Ì«á ¥L»¡±z̯ण¯à ³o®a.§Ú´N¶R±z̪ºªÑ²¼°Ú.§ë¸ê±z̪ºªÑ²¼°Ú...§Ú»¡ ¥xÆWªºªÑ²¼¤Ó«K©y..¹ï¤£°_ ¤£¦æ ±zn´N¶Rcompound ±z·Q¶R[¤½¥q] §Ṳ́£½æ±z....½Í¨ì³o¼Ë£²...
www.pharmavoice.com/news/pain-med-non-opioid-addiction-free-South-Rampart-Pharma/637665/
¤å¤¤´£¤Îªº¤îµhÃĪ«ACP-044¡A¤µ¦~4¤ë«Å¥¬¸ÕÅ祢±Ñ!
ACP-044¦b2020¦~±ÂÅv»ùÈ(8.87 »õ¬ü¤¸):
®Ú¾Ú¥æ©ö¡AACADIA ¥H 5250 ¸U¬ü¤¸ªº»ù®æÁʶR¤F CerSci ªº©Ò¦³¬y³qªÑ¡C¦¹¥~¡A¦pªGÀò±o§åã¡ACerSci ªÑªF¥i¯à·|Àò
±o°ª¹F 8.87 »õ¬ü¤¸ªº¶}µo¡B°Ó·~©M¾P°â¨½µ{¸O¡A¥H¤Î²b¾P°âÃBªº¤¤µ¥Ó¦ì¼Æ¯S³\Åv¨Ï¥Î¶O¡C
-----------------------------------------------------------------------------------------
·|û¡GROGER588910148151 µoªí®É¶¡:2021/9/23 ¤U¤È 01:10:22²Ä 1420 ½g¦^À³
23»õ¬ü¤¸±ÂÅvª÷ªº·s«¬¤îµhÃÄ¡A3¤ë¦b¬ü°êFDA½²î¡A¤W¶g¤S¦b¼Ú¬wEMA½¨®!
ªvÀø°©Ãö¸`ª¢(osteoarthritis)¤SºÙ¬°°h¤Æ©ÊÃö¸`ª¢ªº²Ä1½uÃĪ«:¤AñQÓi×ô»P«DÃþ©T¾J®øª¢¤îµhÃÄ(NSAID).
2006¦~¡A辉·çªá¤F约5亿¬ü¤¸¦¬购Rinat Neuroscience¡A进¦Ó获±o¤FTanezumab¡Cþ÷来¦b2013¦~ÉO辉·ç签订¤F¤@¥÷°ª达18亿¬ü¤¸ªº协议...
¬°¤°»ò South Rampart Pharma ªº·s«¬¤À¤l¥i¯à¦¨¬°¸Ñ¨M¥þ²y¯kµh¬y¦æ¯fªºÃöÁä¡C
www.pharmavoice.com/news/pain-med-non-opioid-addiction-free-South-Rampart-Pharma/637665/
¦pªG±z¦¨¥\±N¨ä±À¦V¥«³õ¡A±z¬Æ¦Ü¥i¥H¹w´ú¸ÓÃĪ«ªº»ùȬO¦h¤Ö¡H
------------------------------------------------------------------------------------------------
·|û¡GROGER588910148151 µoªí®É¶¡:2022/10/21 ¤U¤È 12:33:43²Ä 2636 ½g¦^À³
²Ä2®a¬ü°ê¶¤South Rampart Pharmaªº SRP-001¨S¦³¨x¬r©Ê¨S¦³µÇ¬r©Ê--Á{§É¸ÕÅç¦h¾¯¶q»¼¼W(MAD)¨ì4000mg(4g)???
¹wpP1µ²ªG±N¦b 2023 ¦~²Ä¤G©u«×¤½§G¡C
1. 2021.3.16 Hsd17b13 ¯Ê³´¤£¯à«OÅ@¤p¹«§K¨üPªÎD©Ê¶¼¹·l¶Ë
www.ncbi.nlm.nih.gov/pmc/articles/PMC8627256/
2. 2022.7.16(2011¦~¿Õ¨©º¸¥Í²zÂå¾Ç¼ú±o¥DBruce Beutlerªº½×¤å)
www.nature.com/articles/s41467-022-31812-4
...³Ìªñªº¤@½g½×¤å³ø¾É¤F¤@Ó¤£¦PªºÆ[¹îµ²ªG¡A§YHsd17b13°ò¦]ºV°£¤p¹«¦b´XºØ¯×ªÕ¨x»¤¾Éªº¶¼¹±ø¥ó¤U¡A¦b¨x¯×ªÕÅÜ
©Ê¡B¨x·l¶Ë¡BÅÖºû¤Æ©Mª¢¯g¤è±»P WT ¤p¹«¨S¦³®t²§!
3. 2022.1.7 («nì³ÐªÌ:Ĭ¤å) www.ncbi.nlm.nih.gov/pmc/articles/PMC8776652/
¥O¤HÅå³Yªº¬O¡A³Ìªñ¹ï HSD17B13 °ò¦]ºV°£¤p¹«ªº¬ã¨sªí©ú¡AHSD17B13 ¯Ê¥F¯g¥¼¯à«OÅ@¨xŦ§K¨ü°ª¯×ªÕ¶¼¹¡B¦è¤è¶¼
¹©M°sºë¼ÉÅS¤Þ°_ªº¯×ªÕÅÜ©Ê·l¶Ë¡A³oªí©ú HSD17B13 ¯Ê¥F¯g¥i¯à¹ï¤p¹« NAFLD ¨S¦³«OÅ@§@¥Î¼Ò«¬¡C¦P¼Ë¡A¥t¤@²Õ³ø
§i»¡¡A¯Ê¥F HSD17B13 °ò¦]ªº¤p¹«¦b 9 Ó¤ë¤j®É¦b¥¿±`¶¼¹¤U¦Ûµoµo®i¬°¿ðµo©Ê¯×ªÕ¨x.³o¨Ç·N·Q¤£¨ìªºµ²ªG¥Ø«e¯Ê¥F
¾÷¨î¸ÑÄÀ¡A»Ýn¶i¤@¨B¬ã¨s¡C
----------------------------------------------------------------------------------------------------
·|û¡GROGER588910148151 µoªí®É¶¡:2022/12/3 ¤U¤È 01:47:05²Ä 2700 ½g¦^À³
GSKªº10»õ¬ü¤¸±ÂÅvª÷¡A«nì³ÐªÌ¦b2014¦~µoªíªº½×¤å©~µM¦³[±m³J]Åå³ß!
¥»¶g¸ÉÓ¦ì¼Æ¦^·í©`¦Ì¤á
========================
ºÃ? 2¦ì¶^¯}¤d«á¡A´X¶g¨Ó«ç»ò¤£½æ¤F???
2022.11.30--GSK is a potential buyout candidate for Novartis - Intron Health
±m³JP values <0.01:
retinol metabolism:ARO-HSD¬O°w¹ï³o¤@¹vÂI³]pªºRNAiÀøªk¡A¥i¥H§í¨î³o¤@°ò¦]ªí¹FªºHSD17£]13³J¥Õ(¨xŦµø¶À¾J²æ²B酶)ªº²£¥Í--->GSKªº10»õ¬ü¤¸±ÂÅvª÷!
metabolism of xenobiotics by cytochrome P450, drug metabolism--->SNP-610»PSNP-630
1. 2022.11.19 奋¤æªÌ¨¬迹 | °ò础¬ì¬ã´N¬O¦bÆÓ数¦¸¥¢败¤¤«e¦æ
m.mp.oeeee.com/a/BAAFRD000020221119741302.html
2. 2014½×¤å: www.pnas.org/doi/10.1073/pnas.1410741111
... Interestingly, a group of cytochrome P450 family proteins, such as cyp2E1, cyp4A11, and cyp2C9, was also found to be associated with the LDs and up-regulated in fatty liver, perhaps suggesting that these cytochrome P450 enzymes are involved in the development of NAFLD
...there was an enrichment in 4 KEGG pathways with P values <0.01 (i.e., retinol metabolism, metabolism of xenobiotics by cytochrome P450, drug metabolism, and linoleic acid metabolism) (SI Appendix, Table S8). In the retinol metabolism pathway, 11 enzymes involved were up-regulated in the LDs of fatty livers
------------------------------------------------------------
·|û¡GROGER588910148151 µoªí®É¶¡:2021/11/26 ¤U¤È 11:03:33²Ä 1487 ½g¦^À³
¤p¤À¤lÃĪ«»PRNAÀøªk¦a¼Æ¾Ú:
SNP-610 ALT¡BAST显µÛ¤U°
mops.twse.com.tw/nas/STR/663420190724M001.pdf
VS
2021.11.23---GSK¯{10»õ¬ü¤¸Äâ¤âArrowhead ¶}µo«D°sºë©Ê¯×ªÕ¨xRNAiÀø(¹w¥I1.2»õ¬ü¤¸)
www.drugtimes.cn/2021/11/26/10yimeiyuangskyinjinarowheaddenashrnailiaofa/
100mg¥H¤W剂¶q组¡AALT¡BAST显µÛ¤U°
¤j·§¬O¦~ªì¨´¤µ¡A«ùªÑ¤d±i¥H¤W¡A¨C¶g©T©w½æ¥X´X¤Q±i¡A§Ú¤£t³d¥ôªº±À´ú¥X¨º2¤H!
----------------------------------------------------------------------------------------------------
ºÃ? 2¦ì¶^¯}¤d«á¡A´X¶g¨Ó«ç»ò¤£½æ¤F???
Cordyceplen²q´ú¬O Cordycepin + Ceplene ªº¤Æ¦Xª«???
1.J¥®®E §Ü¯f¬r药ªü©õ¬¥韦经¥Ö§l¦¬¨î剂.pdf - 专§Q -¥d敌ûÒ(Cordycepin)
www.zhuanlichaxun.net/p-319243.html
2. 2019.6.14 Âίó¯À(Cordycepin)ªºªvÀø¼ç¤O©M¥Íª«¾ÇÀ³¥Î¥H¤Î²£Âίó¯À¯uµßªº¥NÁ¾÷¨î
www.mdpi.com/1420-3049/24/12/2231/htm
3.2021.2.12 Âίó¯À(Cordycepin)³q¹L¿E¬¡ AMP ¿E¬¡³J¥Õ¿E酶«H¸¹³q¸ô§ïµ½«D°sºë©Ê¯×ªÕ©Ê¨xª¢
aasldpubs.onlinelibrary.wiley.com/doi/full/10.1002/hep.31749
Ceplenitol
1. Ceplen: Histamine dihydrochloride¡]°Ó«~¦WCeplene¡^¬O¤@ºØ²ÕÓiÆQ¡A¤]¬O FDA §å㪺§½³¡Âíµh¬¡©Ê
¦¨¤À¡A¥Î©ó¼È®É½w¸Ñ»PÃö¸`ª¢¡B³æ¯Â©ÊIµh¡B·ï¶Ë¡B§á¶Ë©M©Ô¶Ë¬ÛÃöªº¦Ù¦×©MÃö¸`ªº»´·L¯kµh©M¯kµh¡A
nitol:mannitol(¥ÌÅS¾J) SNP-810½á§Î¾¯
2.2020.11.26 ¥ÌÅS¾J¼W±jf®ü©Ô©ú(Diphenhydramine)§@¬°´À¥N§½³¡³Â¾K¾¯ªºÂíµh§@¥Î
www.ncbi.nlm.nih.gov/pmc/articles/PMC7714595/
³Ìªñ³ø¾É¥ÌÅS¾J¥i¦³®Ä¼W±j§Q¦h¥d¦]ªºÂíµh§@¥Î¡C
...¥»¬ã¨sº¦¸ÃÒ©ú¥ÌÅS¾J¥i¼W±jf®ü©Ô©úªºÂíµh§@¥Î¡C
µù¥U¤é´Á2018-3-1 FATTIDOTE ¦r¸q¤WÀ³¸Ó¬O´î«ÃÄ
µù¥U¤é´Á2021-10-1 Cordyceplen
µù¥U¤é´Á2021-12-1 Ceplenitol
2021.1.7 ¼¶¤å | 陈¤åüL¡]«¢¦ò¤j学³Õ¤h¦Z¡^(2020.10.28 nature¤å³¹¾ÉŪ)
www.linkresearcher.com/theses/2c809fcd-0744-4f49-a040-53d3a1705a13
CYP2E1ªí达阳©Êªº¯×ªÕ细M¥i¯à参ÉO调±±产热®Ä应¡C
´£¥ÜALDH1A1+CYP2E1+细M¥i¯àªí达¬Y个®Ç¤Àªc¦]¤l来§í¨î´Ä¦â¯×ªÕ细Mªº产热®Ä应¡C
-------------------------------------------------------------------------------------------------
·|û¡GROGER588910148151 µoªí®É¶¡:2022/5/27 ¤W¤È 11:15:56²Ä 2021 ½g¦^À³
...2.2020.10.28 Nature³o½g:www.nature.com/articles/s41586-020-2856-x
...µo²{¤@Ó»P²£¼ö¦³Ãöªº°ò¦] Aldh1a1¡A¸Ó°ò¦]»P Cyp2e1 Ãö«Yºò±K¡CAldh1a1 »P Cyp2e1 ¬V¦âµ²ªG¦b¦UºØ¯×ªÕ²Õ´
¤¤§e²{¥X§¹¬üªº«¦X¡A¶i¤@¨B¦LÃÒ¤F¥¦ÌªºÃö«Y¨Ã¤£¤@¯ë¡C
www.eurekalert.org/news-releases/744765
...¡§·í§Ú̬ݨì¼Æ¾ÚÅã¥Ü¤p¹«ÌÅé«ÆJ´î¡A¶V¨Ó¶V½G¡A§Ú̱±¬Ûòó¡A²ª½¤£´±¬Û«H¦Û¤vªº²´·ú¡C¡¨³o¶µ¬ã¨sªº²Ä¤@§@ªÌMichel Bernier³Õ¤h»¡¹D¡C
------------------------------------------------------------------------------------------------
·|û¡GROGER588910148151 µoªí®É¶¡:2022/11/30 ¤U¤È 10:15:00²Ä 2690 ½g¦^À³
Ê^«4©Pú£轻40%¡I(CYP2E1 §í¨î?)
2020.05.19 www.163.com/dy/article/FCVT73P105349C3F.html
..ªA¥Î双²¸仑ªº¤p¹«们¡A¥X现ªº变¤Æ让¬ì学®a们·P¨ì·N¥~¡C尽ºÞ¤´¦b¦Y°ª¯×ªÕ¹ª«¡A¹¶q¤]没¦³变¤p¡A¥¦们ªºÊ^««D¦ý没¦³¼W¥[¡A还«æ剧¤U°¡C¤×¨ä¬O¤j剂¶q双²¸仑组ªº¤p¹«¡Aµuµu¥|©P内¡AÊ^«³Ì¦hú£轻达40%..
-------------------------------------------------------------------------------------------------
·|û¡GROGER588910148151 µoªí®É¶¡:2022/5/29 ¤W¤È 10:20:26²Ä 2035 ½g¦^À³
¥N谢酶(CYP2E1)ÉO®Ö¨üÊ^(PPAR£\)¤§间¦p¦ó协§@调±±¯×ªÕ´Ä¦â¤Æ¤ÎªÎD发¯f鲜见报¹D¡C
杨¨q伟团队ªº½×¤å´N¬O2022.5¤ë³o½gwww.sciencedirect.com/science/article/pii/S2211383522000545
2020.05.19 www.163.com/dy/article/FCVT73P105349C3F.html
..ªA¥Î双²¸仑ªº¤p¹«们¡A¥X现ªº变¤Æ让¬ì学®a们·P¨ì·N¥~¡C尽ºÞ¤´¦b¦Y°ª¯×ªÕ¹ª«¡A¹¶q¤]没¦³变¤p¡A¥¦们ªºÊ^««D¦ý没¦³¼W¥[¡A还«æ剧¤U°¡C¤×¨ä¬O¤j剂¶q双²¸仑组ªº¤p¹«¡Aµuµu¥|©P内¡AÊ^«³Ì¦hú£轻达40%..
----------------------------------------------------------------------------------------------
·|û¡GROGER588910148151 µoªí®É¶¡:2022/5/27 ¤U¤È 12:12:56²Ä 2024 ½g¦^À³
..FDA §å㪺¥Î©óªvÀø°sºë¤¤¬rªºÃĪ«Âù²¸±[ [¨ã¦³±j¤jªº§ÜªÎD§@¥Î]¡A¦Ó³o¨Ã«D³q¹L¨ä¹ïîDzæ²B酶2(ALDH2)ªº§í»s§@¥Î¨Ó¹ê²{ªº¡C¦bµ²ºc¤W¡AÂù²¸±[¥i¥H¥NÁ¦¨ DDC¡ACYP2E1 §í»s¾¯¡A¦]¦¹¥i¥H¦X²z¦a±ÀÂ_Âù²¸±[ªº§@¥Î¥i¯à¬O³q¹L¨ä¥NÁª« DDC ¤¶¾Éªº CYP2E1 §í¨î¡C
----------------------------------------------------------------------------------------------
SNP¤]¸Ó±´¨s¤@¤U´îªÎ®ÄªG!
1. 2022.4.¤ëwww.sciencedirect.com/science/article/pii/S2352345X22000637
§Ú̪º¬ã¨sµ²ªG´¦¥Ü¤F¤@Ó¥H«e¥¼³Q»{ÃѪº¾÷¨î¡A¨ä¤¤ MBL-HSC ¬Û¤¬§@¥Î«P¶i HSC °I¦Ñ©MÀH«áªºÅÖºû¤Æ½w¸Ñ¡A¬°»P¨xÅÖºû¤Æ¬ÛÃöªº CLD ªºªvÀøµ¦²¤´£¨Ñ¤F¨£¸Ñ¡C
³o¨Ç¼Æ¾Úªí©ú¡A¨xŦ MBL ªí¹Fªº«ì´_½w¸Ñ¤F¥Ñ©ó MBL ¯Ê¥F¤Þ°_ªº¨xÅÖºû¤Æ¶i®i¡A³o·N¨ýµÛ MBL ¦³§U©ó§ïµ½¨xÅÖºû¤Æ¶i®i¡C«ì´_¨x MBL ªí¹F´X¥G§¹¥þ®ø°£¤F¥Ñ©ó MBL ¯Ê¥¢¾ÉPªº¨xÅÖºû¤Æ¥[«¡A´£¨Ñ¤F MBL ¦³§U©ó§ïµ½¨xÅÖºû¤ÆªºÃÒ¾Ú¡C
Á`¤§¡A§Ú̪º¼Æ¾Ú´£¨Ñ¤F¥O¤H«HªAªºÃÒ¾Ú¡AÃÒ©ú MBL ¹ï©ó±±¨î¨xÅÖºû¤Æ¶iµ{¦ÜÃö«n
2. 2008¦~ pubmed.ncbi.nlm.nih.gov/18336595/
»P¤¤«×ÅÖºû¤Æ±wªÌ¡]F2 ´Á¡^¬Û¤ñ¡A««×ÅÖºû¤Æ±wªÌ¡]F4 ´Á¡^»P§C¤ô¥MBL¡]XA/XA¡BXA/YO ©M YO/YO¡^¬ÛÃöªº°ò¦]«¬Åã
µÛ°§C¡]P = 0.04) ©M¹ï·Ó²Õ (P = 0.011)¡C
----------------------------------------------------------------------------------------------------
·|û¡GRock00910149258 µoªí®É¶¡:2022/10/19 ¤U¤È 05:04:37²Ä 2619 ½g¦^À³
1.¨Æ¹êµo¥Í¤é:111/10/19...¤@¡BSNP-630ªvÀøªº¤p¹«ªº¨xµoª¢¡B¨x¯×ªÕÅÜ©Ê©MÅÖºû¤Æ±o¨ìÅãµÛ§ïµ½¡A¨äALT¤ô¥¡B
ÅÖºû¤Æ¬ÛÃö¥Íª«¼Ð°O¡]§Yalpha-SMA¡BCol1a1¡BCol3a1©MTimp-1¡^§¡ÅãµÛ°§C¡C
-------------------------------------------------------------------------------------------------
·|û¡GROGER588910148151 µoªí®É¶¡:2022/7/3 ¤W¤È 08:30:15²Ä 2172 ½g¦^À³
F4°ò¥»ºâ¬O¥Ø«eÃĪ«¬ãµoªº¸T°Ï¡A¯e¯f¶i®i¨ì¨xµw¤Æ¤§«á¦A°fÂà¬O«D±`§xÃøªº¡A¦pªG¯à°µ¥XÀø®Ä¡A¯uªº´N¤jº¡³e¤F¡C
©Ò¥HSNP-610´Á¤¤¤ÀªR:F4ªº²Õ¡AªvÀø«e«á¦³[ÅãµÛ®t²§]---¹Ú´K¥H¨D¦Ó¥B¬Ý¨ì$$$ª÷¥ú°{°{$$$
©³¤Uªº¬ã¨s½×¤å»P¼v¤ù¦³µª®×!(¥ÌÅS¾J»P¤T´â½©¿}-->MBL-->§í¨îCYP2E1-->´î¤ÖAPAP¨x¬r©Ê)
1. 2019.2.1 ¥ÌÅS»EÁÞµ²¦X¾®¶°¯À(MBL)³q¹L ROS ¨Ì¿à©Ê JNK/SP1 ³q¸ô½Õ¸` CYP2E1 ªí¹F¡A±q¦Ó´î»´¹ï¤A酰®ò°ò×ô»¤¾Éªº¨x¬r©Ê
onlinelibrary.wiley.com/doi/full/10.1002/eji.201847830
MBL ¬O¤@ºØ·½¦Û¨xŦªº´`Àô¦å¼ß³J¥Õ....³o¨Ç¼Æ¾Úªí©ú MBL ¦b APAP »¤¾Éªº«æ©Ê¨x·l¶Ëªºµo¯f¾÷¨î¤¤§í¨î CYP2E1 ªí¹F¡C
2.Lectin Pathway of Complement System
www.youtube.com/watch?v=9Y0q_z2o-_c
¾®¶°¯À³~®|©l©ó¥ÌÅS¿}µ²¦X¾®¶°¯À (MBL) ©Î»P¬Y¨Ç¿}µ²¦XªºÅÖºû½¦³J¥Õ¡C¦b¸Ó³~®|¤¤¡Aµ²¦X¥ÌÅS¿}ªº¾®¶°¯Àµ²¦X¥ÌÅS¿}¡B¸²µå¿}©Î¨ä¥L¨ã¦³ 3- ©M 4-OH °ò¹Îªº¿}
2022.8¤ë-J&J¶}µoªºµL¨x¬rTylenol(JNJ-10450232)¬ã¨s³ø§i
www.sciencedirect.com/science/article/abs/pii/S0273230022001234
JNJ-10450232 (NTM-006) ¬O¤@ºØ·sªº¤À¤l¹êÅé¡A¨äµ²ºc»P¹ï¤A酰®ò°ò×ô¬Û¦ü¡A¥i¦b°Êª«©M¤HÃþ¤¤´£¨ÑÃþ¦üªºÂíµh§@¥Î¡A¦Ó¤£·|¦bÁ{§É«e¼Ò«¬¤¤¤Þ°_»P¹ï¤A酰®ò°ò×ô¹L¶q¬ÛÃöªº¨x¬r©Ê¡C
¦h¾¯¶qµ¹ÃÄ«á¡A¶À´³¥Ö¯l©M¥þ¨©Ê¬õ´³¬O³Ì±`¨£ªºÃĪ«¬ÛÃö¤£¨}¨Æ¥ó¡C
------------------------------------------------------------------------------------------------
¹ïSNP-810¤£ºc¦¨«Â¯Ù¡A¤è¤è±±¨Ó¬ÝSNP-810¬Ò³Ó¥X!
1.J&J¦b2019.10.10±NJNJ-10450232½æµ¹Neumentum¤½¥q(NTM-006)
www.thepharmaletter.com/article/neumentum-nabs-j-j-pain-molecules
2.P2¸ÕÅç°±¯d¦b2017¦~clinicaltrials.gov/ct2/show/NCT02209181?term=JNJ-10450232&draw=2&rank=1
3.³o¤äNTM-006»P¤§«e´£¹Lªº3®a¬ü°ê¶¤¦P¼Ë¬OAPAPµ²ºcÃþ¦üª«¡A±q쪫®Æ»P»sµ{³]³ÆÅܰʪº»s³y¦¨¥»¡A»PAPAPµ²ºcÃþ¦üª«¦s
¦³ªº¦w¥þ©ÊµS¥¼ª¾?(SNP-810½á§Î¾¯:¥ÌÅS¾J»P¤T´â½©¿}¦bÂåÃÄ·~»P¹«~·~¤w¨Ï¥Î¼Æ¤Q¦~)
2022.11.24¥@¤W³Ì¶QÃľ¯Àòã¤W¥« ¤A«¬¦å¤Í¯f°ò¦]Àøªk¨C¾¯©w»ù¶W¹L1»õ¤¸¥x¹ô
FDA§åã¿D¬wÃļtCSL Behringªº¤A«¬¦å¤Í¯fªº°ò¦]ÀøªkHemgenix¡A³o¬O¤@ºØ¤@¦¸©Ê¿é²G¡A¦³§U±wªÌ§K©ó±`³WªvÀø¡A¦ý¬OCSL±N¨C¤@¾¯©w»ù¬°350¸U¬ü¤¸¡]¬ù1.09»õ¤¸¥x¹ô¡^¡A¦¨¬°¥@¬É¤W³Ì©ù¶QªºÃĪ«¡C
------------------------------------------------------------------------------------------------
·|û¡GROGER588910148151 µoªí®É¶¡:2022/8/18 ¤U¤È 12:44:04²Ä 2324 ½g¦^À³
¥k¤âÂå«O°ê½Íªk®×¤j¤M¬åÃÄ»ù¡A¥ª¤â¤Sµ¹¤F¥v¤W³Ì©ù¶QªºÃĪ«»ù280¸U¬ü¤¸!
2022.8.18 ¥v¤W³Ì©ù¶QªºÃĪ«©w»ù°ª¹F280¸U¬ü¤¸
...¸zªc¯ÀÃĪ«¬O±q°§C¹¼¤¤Î©µ¿ð±ÆªÅG³¡ªº®ÄªG¨Ó¹F¦¨´îªÎªº®ÄªG¡A¦Ó SNP-610/630 ¬O´î¤Ö¯×ªÕ§Î¦¨¤ÎÂà´«¨x¯×ªÕªº¯S©ÊÅܦ¨¤£¶Ë¨x¡A¤£¬O±q¼ö¶qÄá¨ú·½ÀYµÛ¤â¡A§Ú²q®ÄªG¥i¯à¨S¦³¸zªc¯ÀÃĪ«¨ÓªºÅãµÛ´î¤ÖÅé«¡A¦ýªÖ©w¬O¦³¨ó¦Pªº®ÄªG¡C
------------------------------------------------------------------------------------------------
GLP-1°§C¹¼¤´î¤Ö¼ö¶qÄá¨ú + SNP(§í¨îCyp2e1¼W¥[¼ö¶q®ø¯Ó)-->2ªÌÁpÃĪº¨ó¦P´îªÎ®ÄªG¤j·§·|«ÜÅå¤H!
---------------------------------------------------------------------------
2022.8¤ë¬ã¨s论¤å¡G细M¦â¯ÀP450 2E1°ò¦]ºV°£©Î§í¨î³q过调节¯à¶q®ø¯Ó预¨¾°ª¯×饮¹诱导ªºªÎDwww.sciencedirect.com/science/article/abs/pii/S0006295222002544
¾÷¨î¬ã¨sªí©ú¡ACyp2e1¯Ê¥F¤£¶È¼W¥[´Ä¦â¯×ªÕ²Õ´¡]BAT¡^©M¥Ö¤U¯×ªÕ²Õ´¡]SAT¡^¤¤²£¼ö°ò¦]ªºªí¹F¡A¦Ó¥B«P¶i¨xŦ©MBAT¤¤ªº¯×ªÕ»Ä¥NÁ¡C¯S§O¬O¡ACyp2e1¯Ê¥F³q¹L¼W¥[¨xŦ¥Í¦¨ªº酰°ò¦×ÆP¦Ó¼W¥[¯à¶q®ø¯Ó¡A酰°ò¦×ÆP¥i¥H«P¶i´Ä¦â¯×ªÕ²£¼ö¨Ã¼W¥[£]-®ñ¤Æ¡C
Àø] ªº·sªvÀø¹vÂI¡C
2.´îªÎ·s¤èªk¡I±N¯×ªÕ¡u½ÅÅÜ¡v¥i¼W¿U¯×®Ä²v
¦¶³Í¥Áªí¥Ü...¦P®É±N¥[³t¯×ªÕ¨x·sÃÄSNP-610¶}µo¡Aº¥ý±NÂX¼W1¿ªº¬ãµo¤Hû<--->ªÎDªvÀø¥«³õ¥i¯à¦b 250 »õ¦Ü 270 »õ¬ü¤¸¤§¶¡¡A¤£±´¨sªÎDªvÀø¤Ó¥i±¤¤F!!!
--------------------------------------------------------------------------------------------------
·|û¡GROGER588910148151 µoªí®É¶¡:2022/5/27 ¤W¤È 11:15:56²Ä 2021 ½g¦^À³
1.2022.5¤ë www.sciencedirect.com/science/article/pii/S2211383522000545
³Ìªñªº¬ã¨s¶°¤¤¦b½Õ¸`«DŸ§Ý²£¼ö¥HªvÀøªÎD¯g...½Õ¸`²£¼ö[¯×ªÕ½ÅÅÜ]¡C³o¶µ¬ã¨sªº¤@ÓÅå¤Hµo²{¬O CYP2E1 ¯Ê¥F·|¿E
¬¡¥Õ¦â¯×ªÕ[½ÅÅÜ]¡A¦ñÀHµÛ®Ö¤ß·Å«×©M¯à¶q®ø¯Óªº¼W¥[
2.2020.10.28 Nature³o½g:www.nature.com/articles/s41586-020-2856-x
...µo²{¤@Ó»P²£¼ö¦³Ãöªº°ò¦] Aldh1a1¡A¸Ó°ò¦]»P Cyp2e1 Ãö«Yºò±K¡CAldh1a1 »P Cyp2e1 ¬V¦âµ²ªG¦b¦UºØ¯×ªÕ²Õ´
¤¤§e²{¥X§¹¬üªº«¦X¡A¶i¤@¨B¦LÃÒ¤F¥¦ÌªºÃö«Y¨Ã¤£¤@¯ë¡C
¼Æ¾Úªí©úAldh1a1 / Cyp2e1 +²ÓMªí¹F¤@ºØ®Ç¤Àªc¦]¤l¡A¥¦§í¨î´Ä¦â¯×ªÕ²ÓMªº²£¼ö¥\¯à¡C
3.´îªÎ·s¤èªk¡I±N¯×ªÕ¡u½ÅÅÜ¡v¥i¼W¿U¯×®Ä²v
¥Õ¦â¯×ªÕ²Õ´¡A¦¨¤HÅ餺´X¥G³£¬O³oÃþ«¬ªº¯×ªÕ¡A¥Dn¬O°µ¬°Àx¦s¥H¨Ñ«áÄò¨Ï¥Î¡C
--------------------------------------------------------------------------------------------------
·|û¡GROGER588910148151 µoªí®É¶¡:2022/5/25 ¤U¤È 11:04:16²Ä 2018 ½g¦^À³
CYP2E1 ¯Ê¥F·|¿E¬¡¨xŦ¹L®ñ¤Æª«酶Åé¼W´Þª«¿E¬¡¨üÅé£\ (PPAR£\ )¹v°ò¦]ªºªí¹F¡A¥]¬A¦¨ÅÖºû²ÓM¥Íªø¦]¤l (FGF) 21¡A³o¨Ç°ò¦]¦b±q¨xŦÄÀ©ñ«á¡A·|¼W±j¯×ªÕ½ÅÅÜ©M¯à¶q®ø¯Ó¡A±q¦Ó´î¤ÖªÎD¡C
--------------------------------------------------------------------------------------------------
·|û¡GROGER588910148151 µoªí®É¶¡:2022/6/11 ¤W¤È 09:54:26²Ä 2061 ½g¦^À³
2022.6.10
§ÚÌ¥¿¦b¥H¤@ºØ·sªº¤è¦¡¬Ý«ÝªÎD¡X¡X4 ºØÂåÃĪѥi¯à·|¨ü¯q
..¾Ú´X¦ì¥«³õ¬ã¨s¤HûºÙ¡A2027-28 ¦~ªÎDªvÀø¥«³õ¥i¯à¦b 250 »õ¦Ü 270 »õ¬ü¤¸¤§¶¡
SNP610/630´îªÎ®ÄªG¯à¹F¨ì10%´N¦³¥«³õ¡A¤£¥Î·B¬ü¨ìGLP-1ªº20%!
-------------------------------------------------------------------------------------------------
·|û¡G¶ø¥ì´µ¯S10031727 µoªí®É¶¡:2022/8/16 ¤U¤È 01:47:04²Ä 2317 ½g¦^À³
´î«Ãijq±`¤j¥b®³¤£¨ì«OÀIµ¹¥I¡A¨S·Q¨ì³ºµM¯à½æ³o»ò¦n¡A»á¤H¥O¤H·N¥~¡C ¬d¤F¤@¤U¡Aì¨Ó¥xÆW¤w¸g¦³«Ü¦hÂå¥ÍÀ°·Q´îªÎªº¤H¨Ï¥Î¸zªc¯ÀÃĪ«(off lable use)¡A¥L̳qºÙ½G½G°w¡A¤@¦~ªºÃĪ«¶O¥Î 8~10 ¸U¡C
Ò\«e¸pªø´¿°Ý¹LJ±Ð±Â¡ASNP-610/630 ¯à¤£¯à·í´îªÎÃĨϥΡAJ¯ºµÛ¦^»¡¤£¦æ¡C±µµÛ¤S»¡ªA¥Î SNP-610/630 ´Nºâ¦³¯×ªÕ¨x¤]¤£¦AÅܦ¨¯×ªÕ¨xª¢¡A¤£¥²´îªÎ¡C
¸zªc¯ÀÃĪ«¬O±q°§C¹¼¤¤Î©µ¿ð±ÆªÅG³¡ªº®ÄªG¨Ó¹F¦¨´îªÎªº®ÄªG¡A¦Ó SNP-610/630 ¬O´î¤Ö¯×ªÕ§Î¦¨¤ÎÂà´«¨x¯×ªÕªº¯S©ÊÅܦ¨¤£¶Ë¨x¡A¤£¬O±q¼ö¶qÄá¨ú·½ÀYµÛ¤â¡A§Ú²q®ÄªG¥i¯à¨S¦³¸zªc¯ÀÃĪ«¨ÓªºÅãµÛ´î¤ÖÅé«¡A¦ýªÖ©w¬O¦³¨ó¦Pªº®ÄªG¡C
----------------------------------------------------------------------------------------------
·|û¡GROGER588910148151 µoªí®É¶¡:2022/8/6 ¤U¤È 07:24:51²Ä 2305 ½g¦^À³
2021¦~¿Õ©M¿Õ¼wGLP-1ÃþÃĪ«ºâ¤W´îªÎ»â°ì¦Xp°^ÄmÀ禬¹F95»õ¬ü¤¸!
Y¦bNASH¤]®³¨ìÃÄÃÒ¡A¿Õ©M³o¤äGLP-1ÃÄ(¿}§¿¯f+´îªÎ+NASH)°ª®pÀ禬µ´¹ï¯}200»õ¬ü¤¸¡C
-------------------------------------------------------------------------------------------------
·|û¡GROGER588910148151 µoªí®É¶¡:2022/8/6 ¤U¤È 06:53:40²Ä 2304 ½g¦^À³
«¥ªº20»õ±o©¹¤W+17=37»õ¬ü¤¸¤F!
2022.3.8§â¿}§¿¯f药卖¦¨ú£ªÎ药¡I诺©M诺¼w2025¦~¡§发»}¡¨n卖¨ì37亿¬ü¤¸
www.sohu.com/a/527948439_359980
«UºÙ¡u½G½Gµ§¡vªº©ö¶g¿}µ¥ÃÄ«~¤j¯Ê³f¡A¥x°Ó¤Î¶Q°ü©ê«è¶R¤£¨ìÃÄ¡A¦³ªº¶E©Ò¤§«e¦³§yÃÄ¡A²{¦b©_³f¥i©~¡A¡u쥻1¤ä1000¤¸´N¶R±o¨ì¡A²{¦böt¨ì1¸U¡v¡A»ù®æ½º¦9¦Ü10¿¡A®`¯u¥¿ªº¿}§¿¯f±wªÌªÌ®³¤£¨ìÃÄ¡A¹ê¦b¤ÓÂ÷ÃСC
--------------------------------------------------------------------------------------------
·|û¡GROGER588910148151 µoªí®É¶¡:2022/8/16 ¤U¤È 04:27:24²Ä 2318 ½g¦^À³
§Ú·|¬°¡§¦n¬Ý¡¨¶R³æ´îªÎ!
¡§ÃCȸgÀÙ¡¨: ³o¬O¤@Ó¬ÝÁyªº®É¥N¡A©ÎªÌ»¡¬ÝÃCȪº®É¥N¡C
m.21jingji.com/article/20210530/herald/fd370e54f45dfecbff7049c4877f2ec7_zaker.html
¤W±ªº¤å¦r±Ôz¤£©ö©ú¥ÕSNP-810»P´¶®³¯kªº¨x¬r©Ê®t²§¦³¦h¤j¡AFBªº¤ñ¸û¹Ïªí¥iÅý±z²M·¡©úÁA®t²§¦³¦h¤j!
´¶®³¯k(2g/kg)6°¦¤j¹«¦b1~6¤p®É¤º¦º¥ú VS SNP-810(8g/kg)6°¦¨ì14¤Ñ¥þ¬¡µÛ
-------------------------------------------------------------------------------------------------
·|û¡GROGER588910148151 µoªí®É¶¡:2022/5/19 ¤W¤È 09:36:59²Ä 1994 ½g¦^À³
..www.facebook.com/watch/?v=3194947797458964
³o±i¤j¹«P¦º¾¯¶q¹ÏªíÀ³¸Ó´N¬O¥ÑGLP¹êÅç«Ç§¹¦¨ªº¸ÕÅç?
P2000(mg/kg)´¶®³¯k:6°¦¤j¹«¦b1~6¤p®É¤º¦º¥ú / (S2000(SNP-810)6°¦¤j¹«¦Ü14¤Ñ¥þ¬¡µÛ.
...
P8000(mg/kg)´¶®³¯k:6°¦¤j¹«¦b1¤p®É¤º¥þ¦º /(S8000(SNP-810)1°¦¤j¹«¦b4¤p®É¦º¥h¡A5°¦¤j¹«¨ì14¤Ñ¬¡µÛ.
J³Õ»¡¦A°µ¤@¦¸¹êÅç(S8000(SNP-810)6°¦¨ì14¤Ñ¥þ¬¡µÛ.
±q105¦~³ø:ÄǸtªâ. 1,450±i / ÄÇ·çªl.1,450±i-->·N§Y2¤H¨S¦³°Ñ»P«á¨Óªº´X¦¸¼W¸ê!
³o¼Ë¥i¥H§ä®É¶¡¦^¸É¤F
==========================================================
¤j·§¬O¦~ªì¨´¤µ¡A«ùªÑ¤d±i¥H¤W¡A¨C¶g©T©w½æ¥X´X¤Q±i¡A§Ú¤£t³d¥ôªº±À´ú¥X¨º2¤H!
110.4.12: ÄǸtªâ. 1,450±i / ÄÇ·çªl.1,450±i